Category: Uncategorized

Dr. William Wing-Yan Lo.

Our People Company Directors Independent Director Dr. William Wing-Yan Lo Dr. Lo brings over three decades of biopharma, academic medicine, corporate governance and strategic advisory experience. Dr. Lo graduated from Cambridge University with a Master of Philosophy Degree in Pharmacology and a Ph.D. Degree in Molecular Neuroscience. He started his career in McKinsey & Company […]

Mr. Yat-Pui Au

Our People Company Directors Chief Business Officer Mr. Yat-Pui Au Mr. Au has more than 24 years experience in strategic management and business operations. He joined Regencell in October 2021. Prior to Regencell, he worked at various leading roles in the physical security and property management sectors, where he implemented digital and cloud-based CRM solutions, […]

Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), today announced that Regencell Bioscience Limited (“Regencell HK”), the Company’s wholly-owned subsidiary in Hong Kong, has entered into a joint venture agreement with Honor Epic Enterprises Limited (“Honor Epic”). The joint venture (“JV”) is expected to offer COVID-19 (“COVID”) related treatments to patients in ASEAN countries, India, Japan, Australia and New Zealand. […]

Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”), today announced that the underwriter of its initial public […]

Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company today released a letter from Yat-Gai Au, Founder and Chief Executive Officer of the Company. Dear Shareholders: As CEO of Regencell, I am pleased to take this opportunity to discuss the significant milestones we achieved thus far in 2021, […]